Digital Breast Tomosynthesis Equipment Trends and Forecast
The future of the global digital breast tomosynthesis equipment market looks promising with opportunities in the hospital, and diagnostic center markets. The global digital breast tomosynthesis equipment market is expected to reach an estimated $10.6 billion by 2030 with a CAGR of 14.2% from 2024 to 2030. The major drivers for this market are surging aging population, on-going technological advancement digital breast tomosynthesis equipments, and rising awareness about breast cancer screening.
• Lucintel forecasts that, within the product type category, equipment will remain a larger segment over the forecast period due to technological developments in the field of digital breast tomosynthesis equipment.
• Within the end use category , hospitals will remain the largest segment due to rising prevalence of breast cancer and increasing prefence of cancer patients towards hospitals who are undergoing shortness of breath, pain, and nausea.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to growing breast cancer incidence and improvements in the healthcare infrastructure in the region.
Gain Valuable insights for your business decisions with our comprehensive 150+ page report.
Emerging Trends in the Digital Breast Tomosynthesis Equipment Market
The digital breast tomosynthesis equipment market is evolving rapidly, driven by technological advancements and increasing demand for improved breast cancer screening and diagnosis. DBT, or 3D mammography, enhances the accuracy of breast imaging by providing a detailed, three-dimensional view of breast tissue, which helps in early detection and reducing false positives. As technology progresses, several emerging trends are shaping the market, including advancements in image quality, integration with artificial intelligence, and expanding applications. These trends reflect the ongoing innovation and growth within the digital breast tomosynthesis sector, addressing clinical needs and improving patient outcomes.
• Integration of Artificial Intelligence: The integration of AI into digital breast tomosynthesis systems is a significant trend, enhancing image analysis and diagnostic accuracy. AI algorithms assist radiologists by automatically identifying potential abnormalities, reducing reading time, and improving detection rates. Recent developments include AI tools that aid in distinguishing between benign and malignant lesions, offering decision support and reducing the likelihood of false positives. This technology also helps in prioritizing cases based on urgency, thereby streamlining workflow and enhancing overall efficiency in breast cancer screening.
• Advancements in Image Resolution and Quality: Technological advancements are leading to improvements in image resolution and quality for digital breast tomosynthesis systems. Newer models feature higher spatial resolution and contrast, allowing for clearer and more detailed images of breast tissue. This enhancement helps in better visualization of small or dense tumors and reduces the likelihood of missed diagnoses. Innovations include advanced detector technologies and optimized reconstruction algorithms, which contribute to more precise imaging and improved diagnostic confidence for radiologists.
• Hybrid Imaging Systems: The development of hybrid imaging systems that combine digital breast tomosynthesis with other modalities, such as ultrasound or MRI, is gaining traction. These systems provide comprehensive breast imaging solutions by integrating complementary diagnostic technologies. Hybrid systems offer the advantage of combining detailed 3D imaging with additional functional or structural information, improving overall diagnostic accuracy and enabling better treatment planning. This trend reflects a shift towards more holistic approaches in breast cancer diagnosis and management.
• Increased Focus on Patient Comfort: Enhancements aimed at increasing patient comfort during digital breast tomosynthesis procedures are becoming a key trend. Newer digital breast tomosynthesis systems are designed to minimize discomfort and reduce examination time, addressing common patient concerns. Innovations include softer compression paddles, automated positioning systems, and improved ergonomics to enhance the patient experience. These advancements aim to encourage higher patient compliance with screening recommendations and make the diagnostic process less invasive and more patient-friendly.
• Expansion into Emerging Markets: The digital breast tomosynthesis market is expanding into emerging markets with increasing investments and installations in regions such as Asia-Pacific and Latin America. Efforts are focused on making digital breast tomosynthesis technology more accessible and affordable in these regions, where there is a growing demand for advanced breast imaging solutions. Partnerships with local distributors and healthcare providers, along with tailored product offerings, are helping to address the needs of these emerging markets and improve breast cancer detection rates globally.
The digital breast tomosynthesis equipment market is experiencing dynamic changes driven by technological innovations and a growing emphasis on improving breast cancer diagnosis. Emerging trends such as AI integration, enhanced image quality, hybrid imaging systems, patient comfort improvements, and market expansion into emerging regions are shaping the future of digital breast tomosynthesis . These developments are enhancing diagnostic accuracy, patient experience, and accessibility, reflecting a broader commitment to advancing breast cancer care and early detection.
Recent Developments in the Digital Breast Tomosynthesis Equipment Market
Recent developments in the digital breast tomosynthesis equipment market reflect a period of rapid innovation and improvement. As digital breast tomosynthesis continues to gain prominence in breast cancer screening and diagnosis, advancements are emerging that enhance imaging capabilities, patient experience, and integration with other technologies. These developments are driven by ongoing research, technological advancements, and a heightened focus on improving diagnostic accuracy and accessibility. The following outlines five key recent developments in the digital breast tomosynthesis equipment market
• Enhanced Image Resolution and Quality: New digital breast tomosynthesis systems are incorporating advanced detector technologies and imaging algorithms to significantly improve image resolution and quality. Innovations such as higher spatial resolution detectors and optimized reconstruction techniques enable clearer, more detailed images of breast tissue. These advancements help in better visualizing small or dense tumors, thus improving diagnostic accuracy and reducing the rate of false positives. Enhanced image quality supports radiologists in making more precise assessments and helps in early detection of breast cancer.
• Integration of Artificial Intelligence (AI): AI integration in digital breast tomosynthesis systems is becoming increasingly prevalent, offering tools that assist in automated image analysis and interpretation. AI algorithms are designed to detect abnormalities, prioritize cases, and provide decision support, reducing the workload on radiologists and enhancing diagnostic efficiency. These systems can help identify subtle lesions that may be missed by the human eye and offer predictive analytics based on large datasets, contributing to improved early detection and treatment planning.
• Development of Hybrid Imaging Systems: Hybrid imaging systems that combine digital breast tomosynthesis with other modalities, such as ultrasound or MRI, are emerging as a significant trend. These systems provide a more comprehensive approach to breast imaging by integrating the strengths of multiple diagnostic technologies. For example, combining digital breast tomosynthesis with ultrasound can enhance lesion characterization and provide additional functional information. This integrated approach improves overall diagnostic accuracy and supports better clinical decision-making.
• Advancements in Patient Comfort: Recent digital breast tomosynthesis systems are designed with a greater focus on patient comfort. Innovations include softer compression paddles, automated positioning systems, and user-friendly interfaces that reduce discomfort and anxiety during the examination. These advancements aim to make the screening process less invasive and more pleasant for patients, which can lead to higher screening compliance and better patient experiences. Enhanced comfort features are particularly important in encouraging regular mammography screenings.
• Expansion and Accessibility in Emerging Markets: The digital breast tomosynthesis equipment market is expanding into emerging markets, driven by increased investments and efforts to make advanced breast imaging more accessible globally. Companies are working to adapt digital breast tomosynthesis technology to the specific needs and conditions of these regions, including cost-effective solutions and local partnerships. This expansion aims to improve breast cancer detection rates in areas with growing healthcare infrastructure and increasing awareness of the benefits of early screening.
Recent developments in the digital breast tomosynthesis equipment market highlight significant advancements in imaging technology, AI integration, patient comfort, and global accessibility. These improvements are transforming breast cancer screening and diagnosis, enhancing both the accuracy of detection and the overall patient experience. As technology continues to evolve, the digital breast tomosynthesis market is poised to offer even more sophisticated solutions for early breast cancer detection and effective clinical management.
Strategic Growth Opportunities for Digital Breast Tomosynthesis Equipment Market
The digital breast tomosynthesis equipment market is evolving rapidly, offering significant growth opportunities across various applications due to advancements in imaging technology and increasing demand for improved breast cancer detection. digital breast tomosynthesis provides a 3D view of breast tissue, enhancing diagnostic accuracy and reducing false positives. Strategic growth opportunities are emerging as the technology becomes more integrated into clinical practice, with innovations aimed at expanding applications, improving patient outcomes, and increasing accessibility. The following outlines five key growth opportunities within the digital breast tomosynthesis equipment market, highlighting how these applications are poised to drive market expansion.
• Enhanced Diagnostic Accuracy: digital breast tomosynthesis technology offers significant improvements in diagnostic accuracy compared to traditional 2D mammography. The ability to view breast tissue in three dimensions helps in better distinguishing between overlapping structures and identifying small or dense tumors. As the technology advances, there are opportunities to further enhance image resolution and incorporate advanced algorithms to improve detection rates for early-stage breast cancer. This growth opportunity is particularly relevant in regions with high breast cancer incidence, where improved diagnostic tools can significantly impact patient outcomes.
• Integration with Artificial Intelligence (AI): The integration of AI into digital breast tomosynthesis systems represents a major growth opportunity by enhancing image analysis and interpretation. AI algorithms can assist radiologists by automating the detection of abnormalities, prioritizing cases based on urgency, and providing decision support. This integration not only speeds up the diagnostic process but also improves accuracy by highlighting areas of concern that might otherwise be missed. The expansion of AI capabilities in digital breast tomosynthesis systems is expected to drive significant advancements in early detection and personalized treatment plans.
• Expansion into Emerging Markets: There is a growing opportunity to expand digital breast tomosynthesis technology into emerging markets, where increasing healthcare investments and rising awareness about breast cancer screening are creating demand. Tailoring digital breast tomosynthesis systems to meet the specific needs of these regions, such as offering cost-effective solutions and partnering with local healthcare providers, can facilitate market entry and growth. This expansion is crucial for improving breast cancer detection rates in underserved areas and aligns with global health initiatives aimed at increasing access to advanced diagnostic technologies.
• Hybrid Imaging Systems: Developing hybrid imaging systems that combine digital breast tomosynthesis with other modalities, such as ultrasound or MRI, presents a significant growth opportunity. These integrated systems offer comprehensive diagnostic capabilities by combining the strengths of various imaging technologies. For instance, a hybrid system can provide detailed anatomical information from digital breast tomosynthesis alongside functional insights from ultrasound, enhancing lesion characterization and diagnostic accuracy. This trend supports a more holistic approach to breast cancer screening and can lead to better patient management and outcomes.
• Focus on Patient-Centric Features: Investing in patient-centric features in digital breast tomosynthesis systems can drive growth by improving patient experience and compliance. Recent innovations include softer compression paddles, automated positioning systems, and user-friendly interfaces that minimize discomfort during exams. Enhancing patient comfort is crucial for encouraging regular screenings and reducing anxiety associated with mammography. As patient-centric designs become a priority, there is an opportunity to differentiate products in the market and appeal to healthcare facilities focused on providing a better patient experience.
The digital breast tomosynthesis equipment market is positioned for strategic growth across various applications. Opportunities to enhance diagnostic accuracy, integrate AI, expand into emerging markets, develop hybrid imaging systems, and focus on patient-centric features are shaping the future of breast cancer screening. Leveraging these growth opportunities can drive advancements in early detection, improve patient outcomes, and broaden the reach of digital breast tomosynthesis technology globally.
Digital Breast Tomosynthesis Equipment Market Driver and Challenges
The digital breast tomosynthesis equipment market is influenced by a range of technological, economic, and regulatory factors that drive its growth and present challenges. As digital breast tomosynthesis technology advances, it addresses key demands for improved breast cancer detection and diagnostic accuracy. However, the market also faces hurdles such as high costs, integration issues, and regulatory complexities. Understanding these drivers and challenges is crucial for stakeholders aiming to navigate the evolving landscape of breast imaging technology.
The factors responsible for driving the digital breast tomosynthesis equipment market include:
• Technological Advancements: Advances in imaging technology significantly drive the growth of the digital breast tomosynthesis market. Enhanced image resolution, improved detector technologies, and sophisticated reconstruction algorithms contribute to more accurate and detailed breast imaging. These technological improvements enable better visualization of dense breast tissue and small lesions, thereby enhancing diagnostic accuracy. Continuous research and development in imaging techniques, such as incorporating AI for automated analysis, further drive the adoption of digital breast tomosynthesis systems in clinical settings, improving early detection rates of breast cancer.
• Increased Demand for Early Detection: Growing awareness about the importance of early breast cancer detection is a major driver for the digital breast tomosynthesis equipment market. With increasing incidences of breast cancer globally, there is a rising demand for advanced diagnostic tools that provide more precise and reliable results. Digital breast tomosynthesis capability to reduce false positives and better differentiate between overlapping structures makes it an attractive option for both patients and healthcare providers. This heightened demand for early and accurate detection propels the market growth and adoption of digital breast tomosynthesis systems.
• Government and Healthcare Initiatives: Government initiatives and healthcare policies promoting breast cancer screening and early detection drive the digital breast tomosynthesis market. Programs that support regular mammography screenings and provide funding for advanced diagnostic technologies help expand access to digital breast tomosynthesis systems. Additionally, initiatives that recommend or mandate the use of digital breast tomosynthesis for specific patient groups further boost market growth. Such policies not only increase the adoption of digital breast tomosynthesis equipment but also contribute to improved patient outcomes and reduced healthcare costs related to late-stage cancer treatment.
• Integration with Artificial Intelligence (AI): The integration of AI in digital breast tomosynthesis systems enhances diagnostic capabilities and drives market growth. AI algorithms assist in automated image analysis, improving the accuracy of tumor detection and reducing radiologistsÄX%$%X workload. This technological advancement supports faster and more accurate diagnoses, leading to better patient management. The incorporation of AI also addresses the shortage of radiologists by providing decision support and prioritizing cases, making it a significant driver for the increased adoption of digital breast tomosynthesis equipment in medical facilities.
• Focus on Patient Comfort and Experience: Enhancements in patient comfort and experience are driving the adoption of advanced digital breast tomosynthesis systems. Innovations such as softer compression paddles, automated positioning, and user-friendly interfaces reduce patient discomfort and anxiety during screenings. Improved patient experience leads to higher compliance with recommended screenings and better overall satisfaction. By addressing patient concerns and making the process more comfortable, manufacturers and healthcare providers can encourage more women to participate in regular breast cancer screenings, thereby driving market growth.
Challenges in the digital breast tomosynthesis equipment market are:
• High Cost of Equipment: The high cost of digital breast tomosynthesis equipment remains a significant challenge for market growth. Advanced imaging technologies and sophisticated features contribute to the high price of digital breast tomosynthesis systems, which can be a barrier for adoption, particularly in smaller healthcare facilities or emerging markets. The substantial investment required for purchasing and maintaining digital breast tomosynthesis equipment may limit access and slow down the widespread adoption of these advanced systems. Addressing cost concerns and developing more cost-effective solutions are crucial for overcoming this challenge.
• Integration with Existing Systems: Integrating digital breast tomosynthesis systems with existing imaging infrastructure and electronic health records (EHR) can be complex and challenging. Compatibility issues between new digital breast tomosynthesis technologies and legacy systems may require additional investments in software and hardware upgrades. Effective integration is essential for ensuring smooth workflows and accurate data sharing. Overcoming these integration challenges involves addressing technical and operational hurdles to facilitate seamless adoption and utilization of digital breast tomosynthesis systems in diverse healthcare settings.
• Regulatory and Compliance Issues: Navigating regulatory requirements and compliance issues is a significant challenge in the digital breast tomosynthesis market. Different countries have varying regulations regarding medical devices, which can impact the approval and marketing of digital breast tomosynthesis systems. Ensuring that digital breast tomosynthesis equipment meets rigorous standards for safety, effectiveness, and performance is critical but can be time-consuming and costly. Manufacturers must stay updated with regulatory changes and work closely with regulatory bodies to streamline the approval process and facilitate market entry.
The digital breast tomosynthesis equipment market is influenced by technological advancements, increasing demand for early detection, supportive government initiatives, AI integration, and a focus on patient comfort. However, challenges such as high equipment costs, integration issues, and regulatory hurdles need to be addressed. Understanding these drivers and challenges is essential for stakeholders to navigate the market effectively and leverage opportunities for growth while overcoming potential obstacles.
List of Digital Breast Tomosynthesis Equipment Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies digital breast tomosynthesis equipment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital breast tomosynthesis equipment companies profiled in this report include-
• Hologic
• GE Healthcare
• Siemens Healthineers
• Dexela
• Fujifilm
• Planmed OY
• Trivitron Healthcare
Digital Breast Tomosynthesis Equipment by Segment
The study includes a forecast for the global digital breast tomosynthesis equipment by product type, end use, and region.
Digital Breast Tomosynthesis Equipment Market by Product Type [Analysis by Value from 2018 to 2030]:
• Equipment
• Upgradation
Digital Breast Tomosynthesis Equipment Market by End Use [Analysis by Value from 2018 to 2030]:
• Hospitals
• Diagnostic Centers
• Others
Digital Breast Tomosynthesis Equipment Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Digital Breast Tomosynthesis Equipment Market
Recent developments in the digital breast tomosynthesis equipment market reflect advancements in technology and increasing adoption across various regions. Digital breast tomosynthesis, an advanced form of 3D mammography, is enhancing early breast cancer detection and diagnostic accuracy. As technology evolves, the market is experiencing significant growth driven by innovations in imaging technology, regulatory approvals, and shifts in clinical practice. Key developments in the United States, China, Germany, India, and Japan highlight these trends and demonstrate how different countries are advancing in the adoption and implementation of DBT technologies.
• United States: In the United States, recent developments in the digital breast tomosynthesis market include the introduction of more advanced digital breast tomosynthesis systems with higher resolution and faster imaging capabilities. Major players, such as Hologic and Siemens Healthineers, have launched new digital breast tomosynthesis models featuring improved contrast and reduced radiation doses. Enhanced artificial intelligence (AI) integration is also a notable trend, offering better image analysis and aiding in early cancer detection. The adoption of digital breast tomosynthesis is growing rapidly in both private and public healthcare settings, supported by favorable reimbursement policies and increasing awareness of its benefits in breast cancer screening and diagnosis.
• China: China is seeing significant progress in the digital breast tomosynthesis market with an increase in domestic production and adoption of digital breast tomosynthesis technology. Chinese companies are developing cost-effective digital breast tomosynthesis systems to meet the needs of the expanding healthcare sector. Recent developments include partnerships between local firms and international technology providers to enhance the quality and affordability of digital breast tomosynthesis equipment. Additionally, there has been a push for upgrading existing mammography units to incorporate digital breast tomosynthesis capabilities. The growing focus on early breast cancer detection, coupled with government support for advanced medical technologies, is driving the market expansion in China.
• Germany: Germany has made notable strides in the digital breast tomosynthesis market with advancements in both technology and clinical application. Recent developments include the introduction of digital breast tomosynthesis systems that offer improved image quality and more efficient workflow integration for radiologists. German hospitals and research institutions are increasingly adopting digital breast tomosynthesis technology to enhance diagnostic accuracy and patient outcomes. The country is also witnessing innovations in hybrid imaging systems that combine digital breast tomosynthesis with other modalities, such as ultrasound, for comprehensive breast imaging. Supportive regulatory frameworks and investment in healthcare infrastructure are contributing to the growth and adoption of digital breast tomosynthesis equipment in Germany.
• India: In India, the digital breast tomosynthesis market is expanding as more healthcare facilities invest in advanced imaging technologies. Recent developments include the entry of new players offering affordable digital breast tomosynthesis systems tailored to the Indian market. The Indian government and private sector are increasingly recognizing the importance of early breast cancer detection, leading to increased installations of digital breast tomosynthesis equipment across various regions. There is also a growing focus on training healthcare professionals to effectively utilize digital breast tomosynthesis technology. Despite challenges such as cost and infrastructure limitations, the market is poised for growth driven by increasing awareness and demand for advanced diagnostic tools.
• Japan: Japan is experiencing significant developments in the digital breast tomosynthesis market, driven by technological advancements and high healthcare standards. Recent progress includes the introduction of digital breast tomosynthesis systems with enhanced imaging capabilities and integration with digital health records for improved patient management. Japanese companies are focusing on innovation and precision, developing digital breast tomosynthesis equipment that supports early breast cancer detection with minimal discomfort for patients. The adoption of digital breast tomosynthesis is supported by strong regulatory frameworks and a high level of investment in medical technology. JapanÄX%$%Xs emphasis on advanced imaging solutions and early diagnosis is fostering the growth of the digital breast tomosynthesis market.
Features of the Global Digital Breast Tomosynthesis Equipment Market
Market Size Estimates: Digital breast tomosynthesis equipment market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Digital breast tomosynthesis equipment market size by product type, end use, and region in terms of value ($B).
Regional Analysis: Digital breast tomosynthesis equipment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, end uses, and regions for the digital breast tomosynthesis equipment market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the digital breast tomosynthesis equipment market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q.1 What is the digital breast tomosynthesis equipment market size?
Answer: The global digital breast tomosynthesis equipment market is expected to reach an estimated $10.6 billion by 2030.
Q.2 What is the growth forecast for digital breast tomosynthesis equipment market?
Answer: The global digital breast tomosynthesis equipment market is expected to grow with a CAGR of 14.2% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the digital breast tomosynthesis equipment market?
Answer: The major drivers for this market are surging aging population, on-going technological advancement digital breast tomosynthesis equipments, and rising awareness about breast cancer screening.
Q4. What are the major segments for digital breast tomosynthesis equipment market?
Answer: The future of the digital breast tomosynthesis equipment market looks promising with opportunities in the hospital, and diagnostic center markets.
Q5. Who are the key digital breast tomosynthesis equipment market companies?
Answer: Some of the key digital breast tomosynthesis equipment companies are as follows:
• Hologic
• GE Healthcare
• Siemens Healthineers
• Dexela
• Fujifilm
• Planmed OY
• Trivitron Healthcare
Q6. Which digital breast tomosynthesis equipment market segment will be the largest in future?
Answer: Lucintel forecasts that equipment will remain the larger segment over the forecast period due to technological developments in the field of digital breast tomosynthesis equipment.
Q7. In digital breast tomosynthesis equipment market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness highest growth over the forecast period due to growing breast cancer incidence and improvements in the healthcare infrastructure in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the digital breast tomosynthesis equipment market by product type (equipment and upgradation), end use (hospitals, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Digital Breast Tomosynthesis Equipment Market, Digital Breast Tomosynthesis Equipment Market Size, Digital Breast Tomosynthesis Equipment Market Growth, Digital Breast Tomosynthesis Equipment Market Analysis, Digital Breast Tomosynthesis Equipment Market Report, Digital Breast Tomosynthesis Equipment Market Share, Digital Breast Tomosynthesis Equipment Market Trends, Digital Breast Tomosynthesis Equipment Market Forecast, Digital Breast Tomosynthesis Equipment Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.